Healthcare

Percheron Therapeutics Expands US Market Presence with OTCQB Uplisti...

Highlights,Percheron Therapeutics uplisted its shares to the OTCQB,market..,American Depository Receipt (ADR) program,terminated,to streamline US trad...

Avicursen Trial Milestone Approaches for Duchenne Muscular Dystrophy

Highlights,Percheron Therapeutics (PER) gears up for key trial data announcement on,avicursen,.,Data focuses on Duchenne muscular dystrophy, an inheri...

Why are Orthocell Ltd (ASX: OCC) Shares Soaring 26% on ASX Today?

Highlights:,Orthocell Reports Successful Completion of Remplir 510(k) Nerve Repair Study,U.S. FDA Clearance Expected in Q1 2025 Following Study Result...

Orthocell Achieves Key Milestone for US Approval of Nerve Repair Sol...

Highlights,Orthocell,(OCC) completes pivotal US FDA 510(k) study for nerve repair product,Remplir,.,Study confirms,Remplir's,safety and effectiveness,...

Revolutionizing Respiratory Imaging: 4DMedical (ASX:4DX) Expands in...

Highlights,4DMedical (4DX) teams up with Perth Radiological Clinic for advanced respiratory imaging,.,XV Technology enables early detection of lung fu...

Syntara’s (ASX:SNT) Strong Annual Performance Despite Revenue Declin...

Highlights,Syntara's (SNT) annual return reaches 87%, outperforming market trends,.,Revenue declines by 7.5% despite strong share price growth,.,The s...

Momentum Builds in ASX Healthcare as Stocks Soar and IPOs Revive Mar...

Highlights,Imricor IMR rises 30% after trial update and licensing agreement.,Vitrafy VFY and Renerve RNV make successful ASX debuts.,ASX healthcare se...

MedAdvisor Limited’s New Share Issuance Reaches ASX

Highlights:,MedAdvisor Limited (ASX:MDR) issues 100,000 fully paid ordinary shares as part of an employee incentive scheme.,The new shares will be quo...

Small-Cap Highlights: European Lithium Leads the Pack with Notable G...

Highlights,Orthocell,gains momentum with its international expansion and distribution deal.,European Lithium surges following a strategic project acqu...

Algorae Pharma’s AI-Driven Cardiovascular Drug AI-168 Shows Promisin...

Highlights,AI-168 shows,cardioprotection,and outperforms beta blockers in studies,.,International patent filed for AI-168, aiming for global market co...

Orthocell's Path to Growth: Record Revenue and Global Expansion Plan...

Highlights,Orthocell,(OCC) reports a 30% annual revenue growth with strong product performance,.,Remplir,™ poised for launch in the US, targeting the,...

Tryptamine (ASX:TYP) Completes Psilocin Study in Obesity

Highlights,Tryptamine Therapeutics concludes Phase 1b study of TRP-8803 in obese participants,.,Study provides insights for Phase 2 development with a...

Pacific Smiles Group Revamps Board Amid Genesis Bidco's Leadership T...

Highlights,Pacific Smiles Group announces significant board restructuring,.,Genesis Bidco holds majority voting power and extends acquisition offer,.,...

Morningstar Ups Pro Medicus Valuation After Major Contract Win

Highlights,Valuation Boost:,Morningstar raises Pro Medicus' fair value estimate by 8% to AU$43 per share.,Revenue Growth:,FY26 revenue forecast increa...

CSL Share Price Struggles in 2024 but Analysts Predict a Strong Rebo...

Highlights,Underperformance in 2024:,CSL shares fell 3% compared to a 10% rise in the ASX 200 index.,Analyst Optimism:,Bell Potter forecasts a 17% ups...

Algorae Pharmaceuticals Appoints Dr. Sarah Siggins to Scientific Adv...

Highlights,New Appointment:,Dr. Sarah Siggins joins Algorae’s scientific advisory board, bringing 14 years of pharmaceutical expertise.,AI Drug Discov...

Strategic Moves Lead to Expansion of Resonance Health’s Global Reach

Highlights:,Resonance Health Ltd (ASX:RHT) has strengthened its position in healthcare technology with its Software-as-a-Medical Device (SaMD) and cli...

Fisher & Paykel Healthcare, Humm, Novonix, and Webjet Shares Experie...

Highlights:,Fisher & Paykel Healthcare shares are down 1.5% after its half-year results, with no guidance upgrade for FY 2025.,Humm Group’s share pric...

Pro Medicus Secures Major 10-Year Contract with Trinity Health

Highlights,Pro Medicus announces a significant $330 million contract with Trinity Health,.,The 10-year deal includes migrating systems to the Visage 7...

Chimeric Therapeutics Gains Financial Boost with R&D Rebate

Highlights,Chimeric Therapeutics (CHM) secures $4.17M R&D tax rebate,.,Funds boost cash reserves, strengthening research potential,.,Focus,remains,on...